Moreover, risperidone, which induces a modest antilipolytic effect, also modestly increases adiponectin levels in treated patients with schizophrenia, wheraes olanzapine decreases the circulating levels of this insulin-sensitizing adipokine [56] and increases pro-inflammatory cytokines [57]. This evidence concerns the gene ADIPOQ and schizophrenia.